GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
UK experts recommend MenB vaccine for 15-year olds following big outbreak - Finance news and analysis from Global Banking & Finance Review
Finance

UK experts recommend MenB vaccine for 15-year olds following big outbreak

Published by Global Banking & Finance Review

Posted on July 16, 2026

2 min read

· Last updated: July 16, 2026

Add as preferred source on Google

UK Committee Recommends MenB Vaccination for 15-Year-Olds After Major Outbreak

Expert Committee Updates MenB Vaccination Guidance Following Outbreak

Background and Recent Outbreak

LONDON, July 16 (Reuters) - All 15 year-olds in Britain should be offered the vaccine against meningococcal B disease (MenB), an expert committee said on Thursday, changing its previous advice after the country's largest outbreak of the disease earlier this year.

The government will now consider the recommendation before making any changes to national vaccination programmes.

Details of the Outbreak

• Two people died in March in a MenB outbreak in Kent, southeast England, which health authorities said was the largest and fastest-growing ever seen in Britain.

Current Vaccination Practices

• Adolescents in Britain — as in many other countries — are not routinely vaccinated against meningitis B, but since 2015, the country has offered a vaccine against the disease to babies.

Committee Review and Recommendations

Review Process

• An independent expert scientific committee was asked to review vaccination plans in the wake of the March outbreak, and has now said teenagers aged about 15 should routinely be offered the vaccine.

Factors Influencing the Recommendation

• The change to advice followed consideration of updated evidence of vaccine effectiveness, uncertainties regarding future disease levels, the recent outbreaks and cost-effectiveness analysis.

Effectiveness of Infant Vaccination

• The committee said the MenB vaccine given to infants was "highly effective", and by vaccinating teenagers at 15 they would have protection for the years when they are at a higher risk from the disease.

Additional Vaccination Measures

One-off Vaccination Programmes

• In June, UK health authorities offered a one-off vaccination programme for 17- and 18-year-olds and under 25s who were due to start university later this year.

Risks for Students

• MenB tends to affect students disproportionately as the risk is higher due to close and prolonged contact in halls of residence and at social events.

(Reporting by Sarah Young; editing by William James)

Key Takeaways

  • A MenB outbreak in Kent in March 2026—Britain’s largest ever—prompted the expert panel to reconsider adolescent vaccination policy (gov.uk).
  • JCVI’s updated advice includes offering MenB vaccine to 15‑year‑olds, citing high vaccine effectiveness (85–95%) and protection during high‑risk teenage years (questions-statements.parliament.uk).
  • The government has already initiated a one‑off MenB vaccination campaign for 17‑19‑year‑olds starting university in autumn (england.nhs.uk).

References

Frequently Asked Questions

Why did UK experts recommend the MenB vaccine for 15-year-olds?
Experts changed their advice following the country's largest outbreak of meningococcal B disease, considering updated vaccine effectiveness and increased risk among teenagers.
What changes are proposed for the UK vaccination programme?
The recommendation is to offer the MenB vaccine routinely to 15-year-olds, expanding beyond the current scheme for infants, pending government approval.
Who was affected in the recent MenB outbreak in the UK?
The outbreak in Kent led to two deaths and prompted concern due to its size and rapid spread, particularly affecting adolescents and students.
Is the MenB vaccine currently given to all UK teenagers?
Currently, vaccination is routine for babies, but not for adolescents. A one-off programme has targeted students preparing for university.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category